Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Beatriz Boscardin

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Current Topics in Microbiology and Immunology|August 12, 2025
Dengue VaccinesSilvia Beatriz Boscardin
Experimental Biology and Medicine (Maywood, N.J.)|September 26, 2023
Recombinant antigen delivery to dendritic cells as a way to improve vaccine designGuilherme Antonio de Souza-Silva, Fernando Bandeira Sulczewski, Silvia Beatriz Boscardin
Virus Research|July 7, 2016
Early dengue virus interactions: the role of dendritic cells during infectionHigo Fernando Santos Souza, Bianca da Silva Almeida, Silvia Beatriz Boscardin
Toxicon: X|June 19, 2020
An oligoclonal combination of human monoclonal antibodies able to neutralize tetanus toxin <i>in vivo</i>Eduardo Aliprandini, Daniela Yumi Takata, Ana Lepique, et al.
Virus Research|January 18, 2014
The dengue virus non-structural 1 protein: risks and benefitsJaime Henrique Amorim, Rúbens Prince dos Santos Alves, Silvia Beatriz Boscardin, et al.
Journal of Immunology Research|June 9, 2016
Adjuvants: Classification, Modus Operandi, and LicensingJuliana de Souza Apostólico, Victória Alves Santos Lunardelli, Fernanda Caroline Coirada, et al.
Frontiers in Immunology|November 4, 2022
STAT3 signaling modulates the immune response induced after antigen targeting to conventional type 1 dendritic cells through the DEC205 receptorFernando Bandeira Sulczewski, Larissa Alves Martino, Davi Salles, et al.
Current Research in Immunology|May 2, 2022
STAT6 signaling pathway controls germinal center responses promoted after antigen targeting to conventional type 2 dendritic cellsFernando Bandeira Sulczewski, Larissa Alves Martino, Bianca da Silva Almeida, et al.
Journal of Cellular and Molecular Medicine|January 15, 2010
Chagas' disease: an update on immune mechanisms and therapeutic strategiesSilvia Beatriz Boscardin, Ana Claudia Troccoli Torrecilhas, Romina Manarin, et al.
Frontiers in Immunology|May 21, 2019
Poly(I:C) Potentiates T Cell Immunity to a Dendritic Cell Targeted HIV-Multiepitope VaccineJuliana de Souza Apostólico, Victória Alves Santos Lunardelli, Marcio Massao Yamamoto, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Current Topics in Microbiology and Immunology|August 12, 2025
Dengue VaccinesSilvia Beatriz Boscardin
Experimental Biology and Medicine (Maywood, N.J.)|September 26, 2023
Recombinant antigen delivery to dendritic cells as a way to improve vaccine designGuilherme Antonio de Souza-Silva, Fernando Bandeira Sulczewski, Silvia Beatriz Boscardin
Virus Research|July 7, 2016
Early dengue virus interactions: the role of dendritic cells during infectionHigo Fernando Santos Souza, Bianca da Silva Almeida, Silvia Beatriz Boscardin
Toxicon: X|June 19, 2020
An oligoclonal combination of human monoclonal antibodies able to neutralize tetanus toxin <i>in vivo</i>Eduardo Aliprandini, Daniela Yumi Takata, Ana Lepique, et al.
Virus Research|January 18, 2014
The dengue virus non-structural 1 protein: risks and benefitsJaime Henrique Amorim, Rúbens Prince dos Santos Alves, Silvia Beatriz Boscardin, et al.
Journal of Immunology Research|June 9, 2016
Adjuvants: Classification, Modus Operandi, and LicensingJuliana de Souza Apostólico, Victória Alves Santos Lunardelli, Fernanda Caroline Coirada, et al.
Frontiers in Immunology|November 4, 2022
STAT3 signaling modulates the immune response induced after antigen targeting to conventional type 1 dendritic cells through the DEC205 receptorFernando Bandeira Sulczewski, Larissa Alves Martino, Davi Salles, et al.
Current Research in Immunology|May 2, 2022
STAT6 signaling pathway controls germinal center responses promoted after antigen targeting to conventional type 2 dendritic cellsFernando Bandeira Sulczewski, Larissa Alves Martino, Bianca da Silva Almeida, et al.
Journal of Cellular and Molecular Medicine|January 15, 2010
Chagas' disease: an update on immune mechanisms and therapeutic strategiesSilvia Beatriz Boscardin, Ana Claudia Troccoli Torrecilhas, Romina Manarin, et al.
Frontiers in Immunology|May 21, 2019
Poly(I:C) Potentiates T Cell Immunity to a Dendritic Cell Targeted HIV-Multiepitope VaccineJuliana de Souza Apostólico, Victória Alves Santos Lunardelli, Marcio Massao Yamamoto, et al.
Pageof 5